Reports

Industry Research Reports

Global AI Imaging and Diagnostics System Market Outlook, In‑Depth Analysis & Forecast to 2031

Global AI Imaging and Diagnostics System Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Service & Software

Published Date: 2025-11-16

Pages: 143 Pages

Report ld: 5475123

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global AI Imaging and Diagnostics System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global AI Imaging and Diagnostics System market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • Siemens Healthineers AG
  • GE Healthcare
  • IBM Watson Health
  • Philips Healthcare
  • AliveCor Inc.
  • Zebra Medical Vision, Inc.
  • Riverain Technologies
  • Vuno, Inc.
  • Aidoc
  • Neural Analytics
  • Imagen Technologies
  • Digital Diagnostics, Inc.
  • Google (Subsidiary of Alphabet, Inc.)
  • Heartflow
  • Digital Diagnostics (Formerly Known as Idx)

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Hardware
  • Software

Segment by Application

  • Hospitals
  • Diagnostic Centers
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the AI Imaging and Diagnostics System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.

marn_i1

Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

marn_i1

Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.

marn_i1

Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.

marn_i1

Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.

marn_i1

Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.

marn_i1

Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles

marn_i1

Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.

marn_i1

Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.

marn_i1

Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 14: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to AI Imaging and Diagnostics System: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global AI Imaging and Diagnostics System Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Hardware

1.2.3 Software

1.3 Market Segmentation by Application

1.3.1 Global AI Imaging and Diagnostics System Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Diagnostic Centers

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global AI Imaging and Diagnostics System Revenue Estimates and Forecasts 2020-2031

2.2 Global AI Imaging and Diagnostics System Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

muLu

3 Competition by Players

3.1 Global AI Imaging and Diagnostics System Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global AI Imaging and Diagnostics System Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Hardware Market Size by Players

3.3.2 Software Market Size by Players

3.4 Global AI Imaging and Diagnostics System Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

muLu

4 Global Product Segmentation Analysis

4.1 Global AI Imaging and Diagnostics System Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

muLu

5 Global Downstream Application Analysis

5.1 Global AI Imaging and Diagnostics System Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

muLu

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America AI Imaging and Diagnostics System Market Size by Type (2020-2031)

6.4 North America AI Imaging and Diagnostics System Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America AI Imaging and Diagnostics System Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

muLu

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe AI Imaging and Diagnostics System Market Size by Type (2020-2031)

7.4 Europe AI Imaging and Diagnostics System Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe AI Imaging and Diagnostics System Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

muLu

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific AI Imaging and Diagnostics System Market Size by Type (2020-2031)

8.4 Asia-Pacific AI Imaging and Diagnostics System Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific AI Imaging and Diagnostics System Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

muLu

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America AI Imaging and Diagnostics System Market Size by Type (2020-2031)

9.4 Central and South America AI Imaging and Diagnostics System Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America AI Imaging and Diagnostics System Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

muLu

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa AI Imaging and Diagnostics System Market Size by Type (2020-2031)

10.4 Middle East and Africa AI Imaging and Diagnostics System Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa AI Imaging and Diagnostics System Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

muLu

11 Corporate Profile

11.1 Siemens Healthineers AG

11.1.1 Siemens Healthineers AG Corporation Information

11.1.2 Siemens Healthineers AG Business Overview

11.1.3 Siemens Healthineers AG AI Imaging and Diagnostics System Product Features and Attributes

11.1.4 Siemens Healthineers AG AI Imaging and Diagnostics System Revenue and Gross Margin (2020-2025)

11.1.5 Siemens Healthineers AG AI Imaging and Diagnostics System Revenue by Product in 2024

11.1.6 Siemens Healthineers AG AI Imaging and Diagnostics System Revenue by Application in 2024

11.1.7 Siemens Healthineers AG AI Imaging and Diagnostics System Revenue by Geographic Area in 2024

11.1.8 Siemens Healthineers AG AI Imaging and Diagnostics System SWOT Analysis

11.1.9 Siemens Healthineers AG Recent Developments

11.2 GE Healthcare

11.2.1 GE Healthcare Corporation Information

11.2.2 GE Healthcare Business Overview

11.2.3 GE Healthcare AI Imaging and Diagnostics System Product Features and Attributes

11.2.4 GE Healthcare AI Imaging and Diagnostics System Revenue and Gross Margin (2020-2025)

11.2.5 GE Healthcare AI Imaging and Diagnostics System Revenue by Product in 2024

11.2.6 GE Healthcare AI Imaging and Diagnostics System Revenue by Application in 2024

11.2.7 GE Healthcare AI Imaging and Diagnostics System Revenue by Geographic Area in 2024

11.2.8 GE Healthcare AI Imaging and Diagnostics System SWOT Analysis

11.2.9 GE Healthcare Recent Developments

11.3 IBM Watson Health

11.3.1 IBM Watson Health Corporation Information

11.3.2 IBM Watson Health Business Overview

11.3.3 IBM Watson Health AI Imaging and Diagnostics System Product Features and Attributes

11.3.4 IBM Watson Health AI Imaging and Diagnostics System Revenue and Gross Margin (2020-2025)

11.3.5 IBM Watson Health AI Imaging and Diagnostics System Revenue by Product in 2024

11.3.6 IBM Watson Health AI Imaging and Diagnostics System Revenue by Application in 2024

11.3.7 IBM Watson Health AI Imaging and Diagnostics System Revenue by Geographic Area in 2024

11.3.8 IBM Watson Health AI Imaging and Diagnostics System SWOT Analysis

11.3.9 IBM Watson Health Recent Developments

11.4 Philips Healthcare

11.4.1 Philips Healthcare Corporation Information

11.4.2 Philips Healthcare Business Overview

11.4.3 Philips Healthcare AI Imaging and Diagnostics System Product Features and Attributes

11.4.4 Philips Healthcare AI Imaging and Diagnostics System Revenue and Gross Margin (2020-2025)

11.4.5 Philips Healthcare AI Imaging and Diagnostics System Revenue by Product in 2024

11.4.6 Philips Healthcare AI Imaging and Diagnostics System Revenue by Application in 2024

11.4.7 Philips Healthcare AI Imaging and Diagnostics System Revenue by Geographic Area in 2024

11.4.8 Philips Healthcare AI Imaging and Diagnostics System SWOT Analysis

11.4.9 Philips Healthcare Recent Developments

11.5 AliveCor Inc.

11.5.1 AliveCor Inc. Corporation Information

11.5.2 AliveCor Inc. Business Overview

11.5.3 AliveCor Inc. AI Imaging and Diagnostics System Product Features and Attributes

11.5.4 AliveCor Inc. AI Imaging and Diagnostics System Revenue and Gross Margin (2020-2025)

11.5.5 AliveCor Inc. AI Imaging and Diagnostics System Revenue by Product in 2024

11.5.6 AliveCor Inc. AI Imaging and Diagnostics System Revenue by Application in 2024

11.5.7 AliveCor Inc. AI Imaging and Diagnostics System Revenue by Geographic Area in 2024

11.5.8 AliveCor Inc. AI Imaging and Diagnostics System SWOT Analysis

11.5.9 AliveCor Inc. Recent Developments

11.6 Zebra Medical Vision, Inc.

11.6.1 Zebra Medical Vision, Inc. Corporation Information

11.6.2 Zebra Medical Vision, Inc. Business Overview

11.6.3 Zebra Medical Vision, Inc. AI Imaging and Diagnostics System Product Features and Attributes

11.6.4 Zebra Medical Vision, Inc. AI Imaging and Diagnostics System Revenue and Gross Margin (2020-2025)

11.6.5 Zebra Medical Vision, Inc. Recent Developments

11.7 Riverain Technologies

11.7.1 Riverain Technologies Corporation Information

11.7.2 Riverain Technologies Business Overview

11.7.3 Riverain Technologies AI Imaging and Diagnostics System Product Features and Attributes

11.7.4 Riverain Technologies AI Imaging and Diagnostics System Revenue and Gross Margin (2020-2025)

11.7.5 Riverain Technologies Recent Developments

11.8 Vuno, Inc.

11.8.1 Vuno, Inc. Corporation Information

11.8.2 Vuno, Inc. Business Overview

11.8.3 Vuno, Inc. AI Imaging and Diagnostics System Product Features and Attributes

11.8.4 Vuno, Inc. AI Imaging and Diagnostics System Revenue and Gross Margin (2020-2025)

11.8.5 Vuno, Inc. Recent Developments

11.9 Aidoc

11.9.1 Aidoc Corporation Information

11.9.2 Aidoc Business Overview

11.9.3 Aidoc AI Imaging and Diagnostics System Product Features and Attributes

11.9.4 Aidoc AI Imaging and Diagnostics System Revenue and Gross Margin (2020-2025)

11.9.5 Aidoc Recent Developments

11.10 Neural Analytics

11.10.1 Neural Analytics Corporation Information

11.10.2 Neural Analytics Business Overview

11.10.3 Neural Analytics AI Imaging and Diagnostics System Product Features and Attributes

11.10.4 Neural Analytics AI Imaging and Diagnostics System Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 Imagen Technologies

11.11.1 Imagen Technologies Corporation Information

11.11.2 Imagen Technologies Business Overview

11.11.3 Imagen Technologies AI Imaging and Diagnostics System Product Features and Attributes

11.11.4 Imagen Technologies AI Imaging and Diagnostics System Revenue and Gross Margin (2020-2025)

11.11.5 Imagen Technologies Recent Developments

11.12 Digital Diagnostics, Inc.

11.12.1 Digital Diagnostics, Inc. Corporation Information

11.12.2 Digital Diagnostics, Inc. Business Overview

11.12.3 Digital Diagnostics, Inc. AI Imaging and Diagnostics System Product Features and Attributes

11.12.4 Digital Diagnostics, Inc. AI Imaging and Diagnostics System Revenue and Gross Margin (2020-2025)

11.12.5 Digital Diagnostics, Inc. Recent Developments

11.13 Google (Subsidiary of Alphabet, Inc.)

11.13.1 Google (Subsidiary of Alphabet, Inc.) Corporation Information

11.13.2 Google (Subsidiary of Alphabet, Inc.) Business Overview

11.13.3 Google (Subsidiary of Alphabet, Inc.) AI Imaging and Diagnostics System Product Features and Attributes

11.13.4 Google (Subsidiary of Alphabet, Inc.) AI Imaging and Diagnostics System Revenue and Gross Margin (2020-2025)

11.13.5 Google (Subsidiary of Alphabet, Inc.) Recent Developments

11.14 Heartflow

11.14.1 Heartflow Corporation Information

11.14.2 Heartflow Business Overview

11.14.3 Heartflow AI Imaging and Diagnostics System Product Features and Attributes

11.14.4 Heartflow AI Imaging and Diagnostics System Revenue and Gross Margin (2020-2025)

11.14.5 Heartflow Recent Developments

11.15 Digital Diagnostics (Formerly Known as Idx)

11.15.1 Digital Diagnostics (Formerly Known as Idx) Corporation Information

11.15.2 Digital Diagnostics (Formerly Known as Idx) Business Overview

11.15.3 Digital Diagnostics (Formerly Known as Idx) AI Imaging and Diagnostics System Product Features and Attributes

11.15.4 Digital Diagnostics (Formerly Known as Idx) AI Imaging and Diagnostics System Revenue and Gross Margin (2020-2025)

11.15.5 Digital Diagnostics (Formerly Known as Idx) Recent Developments

muLu

12 AI Imaging and Diagnostics SystemIndustry Chain Analysis

12.1 AI Imaging and Diagnostics System Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

muLu

13 AI Imaging and Diagnostics System Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

muLu

14 Key Findings in the Global AI Imaging and Diagnostics System Study

muLu

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global AI Imaging and Diagnostics System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global AI Imaging and Diagnostics System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global AI Imaging and Diagnostics System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global AI Imaging and Diagnostics System Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global AI Imaging and Diagnostics System Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global AI Imaging and Diagnostics System Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global AI Imaging and Diagnostics System Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global AI Imaging and Diagnostics System by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Imaging and Diagnostics System as of 2024)
Table 11. Global AI Imaging and Diagnostics System Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global AI Imaging and Diagnostics System Companies Headquarters
Table 13. Global AI Imaging and Diagnostics System Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global AI Imaging and Diagnostics System Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global AI Imaging and Diagnostics System Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global AI Imaging and Diagnostics System Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global AI Imaging and Diagnostics System Revenue by Application (2026-2031) & (US$ Million)
Table 21. AI Imaging and Diagnostics System High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America AI Imaging and Diagnostics System Growth Accelerators and Market Barriers
Table 25. North America AI Imaging and Diagnostics System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe AI Imaging and Diagnostics System Growth Accelerators and Market Barriers
Table 27. Europe AI Imaging and Diagnostics System Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific AI Imaging and Diagnostics System Growth Accelerators and Market Barriers
Table 29. Asia-Pacific AI Imaging and Diagnostics System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America AI Imaging and Diagnostics System Investment Opportunities and Key Challenges
Table 31. Central and South America AI Imaging and Diagnostics System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa AI Imaging and Diagnostics System Investment Opportunities and Key Challenges
Table 33. Middle East and Africa AI Imaging and Diagnostics System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Siemens Healthineers AG Corporation Information
Table 35. Siemens Healthineers AG Description and Major Businesses
Table 36. Siemens Healthineers AG Product Features and Attributes
Table 37. Siemens Healthineers AG Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Siemens Healthineers AG Revenue Proportion by Product in 2024
Table 39. Siemens Healthineers AG Revenue Proportion by Application in 2024
Table 40. Siemens Healthineers AG Revenue Proportion by Geographic Area in 2024
Table 41. Siemens Healthineers AG AI Imaging and Diagnostics System SWOT Analysis
Table 42. Siemens Healthineers AG Recent Developments
Table 43. GE Healthcare Corporation Information
Table 44. GE Healthcare Description and Major Businesses
Table 45. GE Healthcare Product Features and Attributes
Table 46. GE Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. GE Healthcare Revenue Proportion by Product in 2024
Table 48. GE Healthcare Revenue Proportion by Application in 2024
Table 49. GE Healthcare Revenue Proportion by Geographic Area in 2024
Table 50. GE Healthcare AI Imaging and Diagnostics System SWOT Analysis
Table 51. GE Healthcare Recent Developments
Table 52. IBM Watson Health Corporation Information
Table 53. IBM Watson Health Description and Major Businesses
Table 54. IBM Watson Health Product Features and Attributes
Table 55. IBM Watson Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. IBM Watson Health Revenue Proportion by Product in 2024
Table 57. IBM Watson Health Revenue Proportion by Application in 2024
Table 58. IBM Watson Health Revenue Proportion by Geographic Area in 2024
Table 59. IBM Watson Health AI Imaging and Diagnostics System SWOT Analysis
Table 60. IBM Watson Health Recent Developments
Table 61. Philips Healthcare Corporation Information
Table 62. Philips Healthcare Description and Major Businesses
Table 63. Philips Healthcare Product Features and Attributes
Table 64. Philips Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Philips Healthcare Revenue Proportion by Product in 2024
Table 66. Philips Healthcare Revenue Proportion by Application in 2024
Table 67. Philips Healthcare Revenue Proportion by Geographic Area in 2024
Table 68. Philips Healthcare AI Imaging and Diagnostics System SWOT Analysis
Table 69. Philips Healthcare Recent Developments
Table 70. AliveCor Inc. Corporation Information
Table 71. AliveCor Inc. Description and Major Businesses
Table 72. AliveCor Inc. Product Features and Attributes
Table 73. AliveCor Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. AliveCor Inc. Revenue Proportion by Product in 2024
Table 75. AliveCor Inc. Revenue Proportion by Application in 2024
Table 76. AliveCor Inc. Revenue Proportion by Geographic Area in 2024
Table 77. AliveCor Inc. AI Imaging and Diagnostics System SWOT Analysis
Table 78. AliveCor Inc. Recent Developments
Table 79. Zebra Medical Vision, Inc. Corporation Information
Table 80. Zebra Medical Vision, Inc. Description and Major Businesses
Table 81. Zebra Medical Vision, Inc. Product Features and Attributes
Table 82. Zebra Medical Vision, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Zebra Medical Vision, Inc. Recent Developments
Table 84. Riverain Technologies Corporation Information
Table 85. Riverain Technologies Description and Major Businesses
Table 86. Riverain Technologies Product Features and Attributes
Table 87. Riverain Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Riverain Technologies Recent Developments
Table 89. Vuno, Inc. Corporation Information
Table 90. Vuno, Inc. Description and Major Businesses
Table 91. Vuno, Inc. Product Features and Attributes
Table 92. Vuno, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Vuno, Inc. Recent Developments
Table 94. Aidoc Corporation Information
Table 95. Aidoc Description and Major Businesses
Table 96. Aidoc Product Features and Attributes
Table 97. Aidoc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Aidoc Recent Developments
Table 99. Neural Analytics Corporation Information
Table 100. Neural Analytics Description and Major Businesses
Table 101. Neural Analytics Product Features and Attributes
Table 102. Neural Analytics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Neural Analytics Recent Developments
Table 104. Imagen Technologies Corporation Information
Table 105. Imagen Technologies Description and Major Businesses
Table 106. Imagen Technologies Product Features and Attributes
Table 107. Imagen Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Imagen Technologies Recent Developments
Table 109. Digital Diagnostics, Inc. Corporation Information
Table 110. Digital Diagnostics, Inc. Description and Major Businesses
Table 111. Digital Diagnostics, Inc. Product Features and Attributes
Table 112. Digital Diagnostics, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Digital Diagnostics, Inc. Recent Developments
Table 114. Google (Subsidiary of Alphabet, Inc.) Corporation Information
Table 115. Google (Subsidiary of Alphabet, Inc.) Description and Major Businesses
Table 116. Google (Subsidiary of Alphabet, Inc.) Product Features and Attributes
Table 117. Google (Subsidiary of Alphabet, Inc.) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Google (Subsidiary of Alphabet, Inc.) Recent Developments
Table 119. Heartflow Corporation Information
Table 120. Heartflow Description and Major Businesses
Table 121. Heartflow Product Features and Attributes
Table 122. Heartflow Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Heartflow Recent Developments
Table 124. Digital Diagnostics (Formerly Known as Idx) Corporation Information
Table 125. Digital Diagnostics (Formerly Known as Idx) Description and Major Businesses
Table 126. Digital Diagnostics (Formerly Known as Idx) Product Features and Attributes
Table 127. Digital Diagnostics (Formerly Known as Idx) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Digital Diagnostics (Formerly Known as Idx) Recent Developments
Table 129. Raw Materials Key Suppliers
Table 130. Distributors List
Table 131. Market Trends and Market Evolution
Table 132. Market Drivers and Opportunities
Table 133. Market Challenges, Risks, and Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. AI Imaging and Diagnostics System Product Picture
Figure 2. Global AI Imaging and Diagnostics System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Hardware Product Picture
Figure 4. Software Product Picture
Figure 5. Global AI Imaging and Diagnostics System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospitals
Figure 7. Diagnostic Centers
Figure 8. Others
Figure 9. AI Imaging and Diagnostics System Report Years Considered
Figure 10. Global AI Imaging and Diagnostics System Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 12. Global AI Imaging and Diagnostics System Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global AI Imaging and Diagnostics System Revenue Market Share by Region (2020-2031)
Figure 14. Global AI Imaging and Diagnostics System Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Hardware Revenue Market Share by Player in 2024
Figure 17. Software Revenue Market Share by Player in 2024
Figure 18. Global AI Imaging and Diagnostics System Revenue Market Share by Type (2020-2031)
Figure 19. Global AI Imaging and Diagnostics System Revenue Market Share by Application (2020-2031)
Figure 20. North America AI Imaging and Diagnostics System Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players AI Imaging and Diagnostics System Revenue (US$ Million) in 2024
Figure 22. North America AI Imaging and Diagnostics System Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America AI Imaging and Diagnostics System Revenue (US$ Million) by Application (2020-2031)
Figure 24. US AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 25. Canada AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 27. Europe AI Imaging and Diagnostics System Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players AI Imaging and Diagnostics System Revenue (US$ Million) in 2024
Figure 29. Europe AI Imaging and Diagnostics System Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe AI Imaging and Diagnostics System Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 32. France AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 34. Italy AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 35. Russia AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific AI Imaging and Diagnostics System Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players AI Imaging and Diagnostics System Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific AI Imaging and Diagnostics System Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific AI Imaging and Diagnostics System Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 41. Japan AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 43. Australia AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 44. India AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore AI Imaging and Diagnostics System Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America AI Imaging and Diagnostics System Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players AI Imaging and Diagnostics System Revenue (US$ Million) in 2024
Figure 52. Central and South America AI Imaging and Diagnostics System Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America AI Imaging and Diagnostics System Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil AI Imaging and Diagnostics System Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina AI Imaging and Diagnostics System Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa AI Imaging and Diagnostics System Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players AI Imaging and Diagnostics System Revenue (US$ Million) in 2024
Figure 58. South America AI Imaging and Diagnostics System Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa AI Imaging and Diagnostics System Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries AI Imaging and Diagnostics System Revenue (2020-2025) & (US$ Million)
Figure 61. Israel AI Imaging and Diagnostics System Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt AI Imaging and Diagnostics System Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa AI Imaging and Diagnostics System Revenue (2020-2025) & (US$ Million)
Figure 64. AI Imaging and Diagnostics System Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global AI Imaging and Diagnostics System market?zhanKai
The top companies in the global AI Imaging and Diagnostics System market are Siemens Healthineers AG、GE Healthcare、IBM Watson Health.
den_biaoTiZhungShi

Related Reports

Global AI Imaging and Diagnostics System Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Service & Software

Published Date: 2025-11-16

Pages: 143 Pages

Report ld: 5475123

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Online

TANG XIN

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

Chinese, English

Online

DAMON

Chinese, English

Online

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now